Progress in gall stone disease.
作者信息
Bateson M C
出版信息
Br Med J (Clin Res Ed). 1984 Nov 3;289(6453):1163-4. doi: 10.1136/bmj.289.6453.1163.
Abstract
摘要
相似文献
1
Progress in gall stone disease.胆结石疾病的进展
Br Med J (Clin Res Ed). 1984 Nov 3;289(6453):1163-4. doi: 10.1136/bmj.289.6453.1163.
2
Gallbladder disease. New trends in diagnosis and management.
Aust Fam Physician. 1984 Jun;13(6):414-5, 417-9.
3
Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.使用溶石性胆汁酸进行胆结石溶解治疗：24例患者的经验
Neth J Med. 1989 Feb;34(1-2):3-9.
4
Gall stone dissolving agents.胆结石溶解剂。
Br Med J (Clin Res Ed). 1983 Mar 5;286(6367):778-80. doi: 10.1136/bmj.286.6367.778.
5
Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.接受体外冲击波碎石术患者的胆结石粉碎策略及熊去氧胆酸维持治疗的随访结果
Gut. 1994 Jan;35(1):117-21. doi: 10.1136/gut.35.1.117.
6
[New approaches to diagnosis and treatment of cholelithiasis in young occupational groups].
Klin Med (Mosk). 1997;75(4):22-3.
7
Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.
Br Med J (Clin Res Ed). 1981 Sep 5;283(6292):645-6. doi: 10.1136/bmj.283.6292.645.
8
[Diagnosis and therapy of gallstone].
Nihon Naika Gakkai Zasshi. 1995 Mar 10;84(3):390-4.
9
Management of stones in the biliary tree.胆管结石的处理
Gut. 1983 Jul;24(7):599-608. doi: 10.1136/gut.24.7.599.
10
Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.胆结石复发及其预防：英国/比利时胆结石研究小组的溶石后试验。
Gut. 1993 Sep;34(9):1277-88. doi: 10.1136/gut.34.9.1277.
引用本文的文献
1
Review of general surgery 1984-85.普通外科综述1984 - 1985年
Postgrad Med J. 1985 Nov;61(721):941-56. doi: 10.1136/pgmj.61.721.941.
本文引用的文献
1
Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application.单辛脂，一种用于溶解残留胆固醇胆管结石的溶石剂：物理性质及临床应用。
Gastroenterology. 1980 May;78(5 Pt 1):1016-22.
2
Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.熊去氧胆酸与鹅去氧胆酸作为胆固醇结石溶解剂的比较：一项随机对照研究。
Hepatology. 1982 Nov-Dec;2(6):804-10. doi: 10.1002/hep.1840020611.
3
Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet.
Dig Dis Sci. 1982 Nov;27(11):1025-9. doi: 10.1007/BF01391750.
4
The natural history of silent gallstones: the innocent gallstone is not a myth.无症状胆结石的自然病史：无害的胆结石并非神话。
N Engl J Med. 1982 Sep 23;307(13):798-800. doi: 10.1056/NEJM198209233071305.
5
Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
J Int Med Res. 1982;10(1):59-63. doi: 10.1177/030006058201000112.
6
Estrogen predisposes to cholecystectomy but not to stones.
Gastroenterology. 1982 Jan;82(1):4-8.
7
Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.熊去氧胆酸：一种安全有效的溶解胆固醇结石的药物。
Ann Intern Med. 1982 Sep;97(3):351-6. doi: 10.7326/0003-4819-97-3-351.
8
Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.胆固醇胆结石患者肝胆汁和胆囊胆汁中胆固醇一水合物晶体的成核作用。
Gut. 1983 Sep;24(9):836-44. doi: 10.1136/gut.24.9.836.
9
Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival.无症状胆结石的预防性胆囊切除术或观察等待处理：一项评估生存情况的决策分析
Ann Intern Med. 1983 Aug;99(2):199-204. doi: 10.7326/0003-4819-99-2-199.
10
[Recurrence and prevention of recurrence after dissolution of gallbladder lithiasis by chenodeoxycholic acid in 22 patients].[22例经鹅去氧胆酸溶解胆囊结石后复发及复发预防情况]
Gastroenterol Clin Biol. 1983 Jun-Jul;7(6-7):605-9.
Zotero 插件